Capricor Therapeutics (CAPR) Leases (2021 - 2025)
Historic Leases for Capricor Therapeutics (CAPR) over the last 6 years, with Q3 2025 value amounting to $13.9 million.
- Capricor Therapeutics' Leases rose 82864.73% to $13.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.9 million, marking a year-over-year increase of 82864.73%. This contributed to the annual value of $1.3 million for FY2024, which is 3597.58% down from last year.
- Capricor Therapeutics' Leases amounted to $13.9 million in Q3 2025, which was up 82864.73% from $939204.0 recorded in Q2 2025.
- Over the past 5 years, Capricor Therapeutics' Leases peaked at $13.9 million during Q3 2025, and registered a low of $939204.0 during Q2 2025.
- Moreover, its 5-year median value for Leases was $2.1 million (2023), whereas its average is $2.7 million.
- Examining YoY changes over the last 5 years, Capricor Therapeutics' Leases showed a top increase of 82864.73% in 2025 and a maximum decrease of 4475.27% in 2025.
- Quarter analysis of 5 years shows Capricor Therapeutics' Leases stood at $2.8 million in 2021, then decreased by 16.72% to $2.3 million in 2022, then decreased by 12.76% to $2.1 million in 2023, then tumbled by 35.98% to $1.3 million in 2024, then surged by 961.29% to $13.9 million in 2025.
- Its Leases was $13.9 million in Q3 2025, compared to $939204.0 in Q2 2025 and $1.1 million in Q1 2025.